Skip to main content
. 2019 Sep 25;34(4):763–770. doi: 10.1038/s41433-019-0591-z

Table 3.

OCTA comparison between eyes of SSc patients and controls

Variable SSc Control p value
Mean ± SD Mean ± SD
FAZ area(mm2) (in SCP) 0.54 ± 0.13 (0.28−0.95) 0.51 ± 0.16 (0.30−0.90) 0.235
FAZ area(mm2) (in full retina) 0.31 ± 0.10 (0.07−0.55) 0.27 ± 0.13 (0.09−0.57) 0.099
Perimeter (mm) 2.12 ± 0.35 (1.12−2.85) 1.95 ± 0.48 (1.18−2.90) 0.051
Acircularity index 1.10 ± 0.03 (1.04−1.20) 1.09 ± 0.02 (1.05−1.13) 0.612
Foveal density (%) 54.23 ± 3.96 (46.78−61.19) 54.68 ± 3.91 (44.02−62.14) 0.593
Vessel density SCP%
 Whole image 49.79 ± 3.47 (42.60−56.30) 51.49 ± 2.89 (43.10−56.50) 0.013*
 Superior-hemi 49.80 ± 3.65 (41.70−56.60) 51.30 ± 2.84 (43.20−55.80) 0.033*
 Inferior-hemi 49.78 ± 3.40 (42.30−56.10) 51.66 ± 3.08 (42.90−57.20) 0.007*
 Fovea 18.20 ± 5.91 (2.10−34.60) 22.20 ± 7.18 (3.70−36.40) 0.005*
 Parafovea 51.45 ± 4.25 (42.90–58.00) 54.23 ± 2.76 (46.10−58.30) P < 0.001*
  Temporal 51.76 ± 4.05 (41.70−57.80) 54.18 ± 2.95 (47.10−58.40) 0.002*
  Superior 51.79 ± 6.22 (35.70−59.00) 55.00 ± 3.37 (46.50−59.90) 0.003*
  Nasal 50.64 ± 3.97 (39.60−58.30) 53.26 ± 3.05 (47.10−60.00) p < 0.001*
  Inferior 52.15 ± 4.61 (43.50−60.10) 54.03 ± 3.37 (43.50−60.00) 0.029*
 Perifovea 50.42 ± 3.75 (42.90−56.30) 52.21 ± 3.27 (42.40−57.90) 0.018*
  Temporal 46.54 ± 3.68 (37.20−57.50) 48.86 ± 3.63 (38.20−57.90) 0.010*
  Superior 50.44 ± 4.20 (40.70−57.10) 52.18 ± 4.20 (40.70−67.10) 0.052
  Nasal 54.34 ± 3.43 (44.40−61.20) 56.01 ± 3.18 (48.00−61.40) 0.019*
  Inferior 50.70 ± 3.88 (43.20−57.50) 52.52 ± 3.87 (42.60−59.20) 0.028*
Vessel density DCP %
 Whole image 51.56 ± 6.52 (39.10−64.10) 52.44 ± 5.43 (38.70−62.10) 0.479
 Superior-hemi 52.00 ± 6.85 (39.70−64.10) 52.98 ± 5.74 (37.50−61.00) 0.446
 Inferior-hemi 50.91 ± 8.00 (36.80−64.20) 51.85 ± 5.29 (20.80−48.50) 0.467
 Fovea 34.61 ± 6.38 (15.50−47.90) 38.16 ± 8.44 (39.90−63.40) 0.044*
 Parafovea 55.57 ± 4.55 (46.10−63.00) 55.87 ± 4.05 (43.00−62.00) 0.744
  Temporal 56.06 ± 4.80 (47.70−64.00) 56.58 ± 3.09 (50.40−61.30) 0.398
  Superior 55.34 ± 5.06 (45.60−63.50) 55.09 ± 3.89 (48.00−60.60) 0.146
  Nasal 56.06 ± 4.49 (47.70−64.80) 56.75 ± 3.94 (48.10−64.70) 0.437
  Inferior 54.17 ± 5.21 (40.70−62.00) 53.74 ± 4.90 (39.30−60.90) 0.684
 Perifovea 52.68 ± 7.12 (38.00−65.60) 54.13 ± 5.78 (38.50−64.20) 0.294
  Temporal 54.73 ± 6.29 (43.00−66.10) 56.52 ± 4.72 (44.20−64.50) 0.130
  Superior 52.53 ± 8.03 (35.90−65.50) 53.66 ± 6.80 (34.00−65.70) 0.475
  Nasal 52.30 ± 7.58 (35.30−65.50) 53.37 ± 6.28 (38.60−64.90) 0.468
  Inferior 51.45 ± 8.18 (34.90−65.50) 52.96 ± 6.44 (34.60−62.10) 0.335
CCP choriocapillaris flow area mm2
 1 mm 2.13 ± 0.12 (1.93−2.68) 2.11 ± 0.12 (1.65−2.38) 0.343
 2 mm 8.70 ± 0.30 (8.03−9.33) 8.63 ± 0.43 (7.16−9.63) 0.396
 3 mm 19.93 ± 0.66 (18.48−21.40) 19.92 ± 0.85 (17.41−21.96) 0.933

All data are presented as the means ± SD

OCTA optical coherence tomography angiography, FAZ foveal avascular zone, SCP superficial capillary plexus, DCP deep capillary plexus

*The value was statistically significant (p < 0.05)